About: BCR-ABL/BCR transcript ratio > 1 and p21Cip overexpression as markers of CML acceleration and progression to blast crisis.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: BCR-ABL/BCR transcript ratio > 1 and p21Cip overexpression as markers of CML acceleration and progression to blast crisis. Goto Sponge Distinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Hladina transkriptů BCR-ABL/BCR transcript ratio > 1 and p21Cip se ukázala jako negativní prognostický faktor pro vývoj chronické myeloidní leukemie. (cs) BCR-ABL/BCR transcript ratio > 1 and p21Cip overexpression were found to be negative prognostic factors for CML development. BCR-ABL/BCR transcript ratio > 1 and p21Cip overexpression were found to be negative prognostic factors for CML development. (en)
Title	BCR-ABL/BCR transcript ratio > 1 and p21Cip overexpression as markers of CML acceleration and progression to blast crisis. Exprese hladiny transkriptů BCR-ABL/BCR ratio > 1 a p21 Cip jako markerů fáze akcelerace CML vede k vypuknutí krize. (cs) BCR-ABL/BCR transcript ratio > 1 and p21Cip overexpression as markers of CML acceleration and progression to blast crisis. (en)
skos:prefLabel	BCR-ABL/BCR transcript ratio > 1 and p21Cip overexpression as markers of CML acceleration and progression to blast crisis. Exprese hladiny transkriptů BCR-ABL/BCR ratio > 1 a p21 Cip jako markerů fáze akcelerace CML vede k vypuknutí krize. (cs) BCR-ABL/BCR transcript ratio > 1 and p21Cip overexpression as markers of CML acceleration and progression to blast crisis. (en)
skos:notation	RIV/00023736:_____/04:I0000011!RIV/2005/MZ0/L33005/N
http://linked.open.../vavai/riv/strany	S245
http://linked.open...avai/riv/aktivita	P
http://linked.open...avai/riv/aktivity	P(NC7550)
http://linked.open...iv/cisloPeriodika	S2
http://linked.open...vai/riv/dodaniDat	2005
http://linked.open...aciTvurceVysledku	Moučková, Darina Moravcová, Jana Klamová, Hana Polívková, Václava Fišer, Karel Polák, Jaroslav
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Ústav hematologie a krevní transfúze
http://linked.open...dnocenehoVysledku	555891
http://linked.open...ai/riv/idVysledku	RIV/00023736:_____/04:I0000011
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	CML;chronic phase;accelerated phase;imatinib mesylate;STI571;BCR-ABL kinetics (en)
http://linked.open.../riv/klicoveSlovo	CML imatinib mesylate accelerated phase chronic phase STI571 BCR-ABL kinetics
http://linked.open...odStatuVydavatele	US - Spojené státy americké
http://linked.open...ontrolniKodProRIV	[1B6C42F1CB38]
http://linked.open...i/riv/nazevZdroje	Hematology Journal
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	6 (xsd:int)
http://linked.open...cetTvurcuVysledku	7 (xsd:int)
http://linked.open...vavai/riv/projekt	Role of BCR-ABL in CML cases with poor response to therapy but with low BCR-ABL transcript levels
http://linked.open...UplatneniVysledku	2004
http://linked.open...v/svazekPeriodika	5
http://linked.open...iv/tvurceVysledku	Klamová, Hana Moravcová, Jana Polák, Jaroslav Fišer, Karel Moučková, Darina Maláčová, R. Zmeková, Vendula
issn	1466-4860
number of pages	1 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 85 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software